WEBVTT - Right to Try, Right to Fail

0:00:00.120 --> 0:00:03.920
<v Speaker 1>I know it's probably too late for me. I made

0:00:03.920 --> 0:00:08.200
<v Speaker 1>my piece with that I need to know before I

0:00:08.280 --> 0:00:14.560
<v Speaker 1>die that my children find themselves in this unenviable position.

0:00:15.240 --> 0:00:20.959
<v Speaker 1>This nation that I probably served will respect their liberties

0:00:21.400 --> 0:00:24.919
<v Speaker 1>and the right to make their own decision about their

0:00:24.960 --> 0:00:35.400
<v Speaker 1>medical treatments. Thank you for having me. Matt Billina is

0:00:35.400 --> 0:00:37.680
<v Speaker 1>a father of three boys and a former U. S

0:00:37.800 --> 0:00:42.800
<v Speaker 1>Naval aviator in he testified at a congressional hearing to

0:00:42.880 --> 0:00:46.440
<v Speaker 1>advocate for dying patients who want access to experimental drugs.

0:00:47.280 --> 0:00:49.440
<v Speaker 1>At that point, his speech was slightly slurred by his

0:00:49.520 --> 0:00:54.080
<v Speaker 1>Luke Garrig's disease. It's a fatal condition with no treatment,

0:00:54.760 --> 0:00:58.279
<v Speaker 1>it destroys the nerve cells and the muscles they control. Slowly,

0:00:58.560 --> 0:01:03.800
<v Speaker 1>every part of the body stops working. Letting patients like

0:01:03.920 --> 0:01:08.120
<v Speaker 1>Matt who have no other options use these experimental medicines

0:01:08.680 --> 0:01:12.720
<v Speaker 1>seems like it should be easy, but it's not that straightforward,

0:01:13.800 --> 0:01:17.120
<v Speaker 1>and the critics, the people who oppose making them widely available,

0:01:17.600 --> 0:01:23.760
<v Speaker 1>aren't always who you would expect. Welcome to Prognosis, a

0:01:23.800 --> 0:01:27.600
<v Speaker 1>podcast about innovation in medicine and science. I'm your host,

0:01:27.680 --> 0:01:30.600
<v Speaker 1>Michelle fay Cortes, and today we're going to explore what

0:01:30.640 --> 0:01:33.240
<v Speaker 1>people do when they're desperate for a chance to try

0:01:33.240 --> 0:01:40.920
<v Speaker 1>an unapproved drug. Do you want to say something? Yeah? Good?

0:01:41.600 --> 0:01:48.880
<v Speaker 1>Do you want to say yes? All right? Laura McGlenn

0:01:48.880 --> 0:01:52.360
<v Speaker 1>is another American who wants access, not for herself but

0:01:52.480 --> 0:01:55.440
<v Speaker 1>for her son, Jordan's. You just heard him in a

0:01:55.480 --> 0:01:58.520
<v Speaker 1>clip from a few years ago, asking lawmakers to make

0:01:58.560 --> 0:02:02.760
<v Speaker 1>it easier he has to shend Muscular dystrophee, a genetic

0:02:02.800 --> 0:02:05.840
<v Speaker 1>disease that erodes the growing muscles of young boys and

0:02:05.880 --> 0:02:09.519
<v Speaker 1>eventually hits the heart and lungs. The average life expectancy

0:02:09.720 --> 0:02:13.880
<v Speaker 1>is twenty six. Jordan was diagnosed when he was almost four,

0:02:14.560 --> 0:02:17.400
<v Speaker 1>and at that time he was diagnosed at our local

0:02:17.440 --> 0:02:20.239
<v Speaker 1>hospital in Indianapolis, which is a pretty big, well known

0:02:20.320 --> 0:02:24.760
<v Speaker 1>children's hospital. But we left there pretty much with no hope,

0:02:24.800 --> 0:02:27.960
<v Speaker 1>and the doctor told us basically, this was a fatal disease,

0:02:28.040 --> 0:02:32.440
<v Speaker 1>no cure, probably nothing even coming up through the pipeline

0:02:32.480 --> 0:02:36.600
<v Speaker 1>that would happen in Jordan's lifetime. It turns out the

0:02:36.639 --> 0:02:40.520
<v Speaker 1>doctors who are wrong. Fast forward now, I mean Jordan's

0:02:41.440 --> 0:02:44.560
<v Speaker 1>is nine and a half and I think, um, there

0:02:44.560 --> 0:02:49.720
<v Speaker 1>are more than forty drugs actually in the investigational stages

0:02:49.919 --> 0:02:53.120
<v Speaker 1>for his disease. So a lot's happened in such a

0:02:53.200 --> 0:03:02.480
<v Speaker 1>short time with the science. First, a little background. The

0:03:02.520 --> 0:03:05.400
<v Speaker 1>easiest way to get access to an experimental drug is

0:03:05.440 --> 0:03:09.240
<v Speaker 1>in a clinical trial, but many people can't participate in trials.

0:03:09.720 --> 0:03:12.919
<v Speaker 1>They may be too sick or too young for them.

0:03:12.960 --> 0:03:17.200
<v Speaker 1>There's something called compassionate use. It's an official program regulated

0:03:17.200 --> 0:03:20.840
<v Speaker 1>by the Food and Drug Administration, but that's also difficult

0:03:20.840 --> 0:03:24.120
<v Speaker 1>to navigate. There's paperwork, and you need the f d

0:03:24.120 --> 0:03:27.120
<v Speaker 1>A s and the drug company's blessing, and it's possible

0:03:27.120 --> 0:03:29.480
<v Speaker 1>that drug company may not give it. There's too much

0:03:29.560 --> 0:03:35.440
<v Speaker 1>risk enter right to try. This is the law that

0:03:35.560 --> 0:03:38.960
<v Speaker 1>Laura McGlenn and Matt Bolina fought for. Its main difference

0:03:39.440 --> 0:03:42.440
<v Speaker 1>it cuts out the f d A. Instead, the doctor

0:03:42.520 --> 0:03:45.800
<v Speaker 1>directly asked the company for a drug. The patients take

0:03:45.840 --> 0:03:49.160
<v Speaker 1>on all the risk and make their own decisions, but

0:03:49.240 --> 0:03:51.120
<v Speaker 1>they do still need to get the drug company to

0:03:51.160 --> 0:03:55.080
<v Speaker 1>go along with it. I'm not gonna lie. I mean,

0:03:55.080 --> 0:03:58.920
<v Speaker 1>when I started this journey, all I could think about

0:03:59.080 --> 0:04:04.400
<v Speaker 1>was my one, my Jordan's. Jordan got lucky, he was

0:04:04.440 --> 0:04:07.600
<v Speaker 1>accepted into a clinical trial, but Laura didn't give up

0:04:07.600 --> 0:04:10.120
<v Speaker 1>her fight for right to try. She did it for

0:04:10.160 --> 0:04:13.480
<v Speaker 1>the other boys, and because the disende community is so close,

0:04:14.000 --> 0:04:16.600
<v Speaker 1>she's seeing firsthand what happens to those who can't get

0:04:16.600 --> 0:04:21.279
<v Speaker 1>into trials. We want our boys to access experimental treatments

0:04:21.279 --> 0:04:25.920
<v Speaker 1>through a clinical trial. Unfortunately, for example Jordan's, he's one

0:04:25.960 --> 0:04:28.839
<v Speaker 1>of sixteen boys in North America that are able to

0:04:28.880 --> 0:04:32.279
<v Speaker 1>try the drug that he's trying. While I watch many

0:04:32.360 --> 0:04:35.200
<v Speaker 1>of my friends who have sons who are amendable to

0:04:35.240 --> 0:04:38.360
<v Speaker 1>the same drug, who can't access the drug because they

0:04:38.360 --> 0:04:41.960
<v Speaker 1>don't qualify for the trial, and so their sons are basically,

0:04:42.200 --> 0:04:45.680
<v Speaker 1>you know, um, continuing to progress through this disease, which

0:04:45.720 --> 0:04:48.599
<v Speaker 1>is a muscle wasting disease, and they're losing muscle function

0:04:48.680 --> 0:04:54.480
<v Speaker 1>and it's it's truly heartbreaking. Mike Smith, a New York attorney,

0:04:54.520 --> 0:04:57.720
<v Speaker 1>also wants better access to medicines. So now, I grew

0:04:57.800 --> 0:05:01.120
<v Speaker 1>up on Long Island, New York, and the town called Sayaucet,

0:05:01.720 --> 0:05:05.239
<v Speaker 1>Um basically had a up until I was fifteen, frankly

0:05:05.279 --> 0:05:10.640
<v Speaker 1>had a perfectly normal and uneventful childhood. That's sort of

0:05:10.720 --> 0:05:13.440
<v Speaker 1>changed on Black Monday, the day of the stock market

0:05:14.160 --> 0:05:19.599
<v Speaker 1>crash on October seven. The day started with Mike scoring

0:05:19.600 --> 0:05:22.040
<v Speaker 1>a goal in a soccer game during his gym class.

0:05:22.800 --> 0:05:26.279
<v Speaker 1>The opposing goalie didn't take it well. He punched Mike

0:05:26.279 --> 0:05:28.599
<v Speaker 1>in the chest and kicked him in the lower right side.

0:05:29.279 --> 0:05:32.240
<v Speaker 1>He immediately fell ill. It was the start of a

0:05:32.279 --> 0:05:36.080
<v Speaker 1>long and harrowing health odyssey. It took five years just

0:05:36.160 --> 0:05:40.240
<v Speaker 1>to get a diagnosis, and we were starting to identify

0:05:40.279 --> 0:05:44.400
<v Speaker 1>that I had a disease or disorder called chronic intestinal

0:05:44.480 --> 0:05:48.120
<v Speaker 1>pseudo obstruction. It is an extreme spastic disorder of the

0:05:48.160 --> 0:05:51.000
<v Speaker 1>digestive track. I'd be sitting in a high school classroom,

0:05:51.040 --> 0:05:54.120
<v Speaker 1>for example, and get a sensation as if my stomach

0:05:54.160 --> 0:05:56.279
<v Speaker 1>was being tied into a shoel. I snot, you know,

0:05:56.320 --> 0:05:58.800
<v Speaker 1>And ever since, I really have never been able to

0:05:58.839 --> 0:06:02.240
<v Speaker 1>take eating or even drink king for granted. Essentially, his

0:06:02.360 --> 0:06:06.200
<v Speaker 1>digestive tract stopped working. For several years, he couldn't need

0:06:06.240 --> 0:06:10.600
<v Speaker 1>at all. He relied on artificial nutrition, and then thankfully

0:06:11.000 --> 0:06:14.560
<v Speaker 1>new drugs came along. He could eat again. But the

0:06:14.560 --> 0:06:17.200
<v Speaker 1>two treatments were pulled from the market in the US

0:06:17.240 --> 0:06:21.080
<v Speaker 1>because of potential side effects, but not in Europe. Mike

0:06:21.200 --> 0:06:25.880
<v Speaker 1>was back to square one. Now here's the thing even

0:06:25.960 --> 0:06:28.320
<v Speaker 1>under right to try he might not get the drugs

0:06:28.320 --> 0:06:32.120
<v Speaker 1>that he knows work for him, because technically it's only

0:06:32.160 --> 0:06:35.919
<v Speaker 1>for people with the terminal diagnosis and Mike's condition. Isn't

0:06:35.920 --> 0:06:39.719
<v Speaker 1>that simple? On the span of my condition at this point?

0:06:40.440 --> 0:06:44.840
<v Speaker 1>Is it chronic and debilitating? Yes? Absolutely? Can we say

0:06:44.880 --> 0:06:48.560
<v Speaker 1>fairly on a day to day basis? Is it life threatening?

0:06:48.880 --> 0:06:51.240
<v Speaker 1>I'm not a doctor. It's not for me to determine

0:06:51.240 --> 0:06:54.400
<v Speaker 1>whether or not it's life threatening. But who should make

0:06:54.440 --> 0:07:00.280
<v Speaker 1>that call? Should patients like Mike have access? Over the

0:07:00.320 --> 0:07:03.039
<v Speaker 1>past five years, more than forty states passed right to

0:07:03.080 --> 0:07:08.640
<v Speaker 1>Try laws. Those efforts culminated in the federal legislation. It

0:07:08.720 --> 0:07:13.040
<v Speaker 1>was a rare bipartisan achievement, pushed by Vice President Mike Pence.

0:07:13.520 --> 0:07:16.360
<v Speaker 1>Right to Try one support in both Houses of Congress.

0:07:16.880 --> 0:07:19.640
<v Speaker 1>It was touted by President Donald Trump in his first

0:07:19.720 --> 0:07:22.560
<v Speaker 1>State of the Union address. He signed it into law

0:07:22.640 --> 0:07:25.880
<v Speaker 1>in May. But this is such a great name. For

0:07:25.920 --> 0:07:28.600
<v Speaker 1>the first day I heard it, It's so perfect right

0:07:28.720 --> 0:07:32.160
<v Speaker 1>to try, and a lot of that trying is going

0:07:32.200 --> 0:07:35.360
<v Speaker 1>to be successful. I really believe that. I really believe it.

0:07:35.880 --> 0:07:40.080
<v Speaker 1>Ibraheim del Pasand is also a believer. More importantly, he's

0:07:40.120 --> 0:07:43.760
<v Speaker 1>the medical director at Houston's Excel Diagnostics. He's also an

0:07:43.800 --> 0:07:48.120
<v Speaker 1>expert in nuclear medicine. That means he uses radioactive materials

0:07:48.320 --> 0:07:53.760
<v Speaker 1>to diagnose and treat patients. Hey, Michelle, Hi, here we go,

0:07:53.880 --> 0:07:58.360
<v Speaker 1>we're working now. Okay, very good. Doctor del Pasand is

0:07:58.400 --> 0:08:01.320
<v Speaker 1>the doctor who is most publicly braced right to try.

0:08:01.520 --> 0:08:04.560
<v Speaker 1>He felt he had no other option. There was a

0:08:04.640 --> 0:08:07.320
<v Speaker 1>drug he wanted to give his patients, a form of

0:08:07.400 --> 0:08:11.040
<v Speaker 1>radiation for neuroendocrine cancer that had been used in Europe

0:08:11.080 --> 0:08:15.440
<v Speaker 1>for years, but it wasn't approved in the US. Steve Jobs,

0:08:15.560 --> 0:08:18.480
<v Speaker 1>the late founder of Apple, went to Switzerland to get it.

0:08:19.000 --> 0:08:22.600
<v Speaker 1>But that's not something that most Americans can do. How

0:08:22.680 --> 0:08:26.600
<v Speaker 1>sick were these patients? I mean majority of these patients

0:08:26.680 --> 0:08:30.440
<v Speaker 1>that I treated, they had a stage four cancer, which

0:08:30.480 --> 0:08:34.680
<v Speaker 1>means that the cancer has already spread throughout the body

0:08:35.320 --> 0:08:39.720
<v Speaker 1>and involved different organs such as livers such as lymph

0:08:39.720 --> 0:08:43.640
<v Speaker 1>notes such as bone, lungs. A majority of these patients

0:08:43.679 --> 0:08:48.320
<v Speaker 1>they were expecting to leave between three to twelve months.

0:08:48.360 --> 0:08:52.679
<v Speaker 1>Mix Meanwhile, there were positive reports out of Europe. American

0:08:52.720 --> 0:08:56.520
<v Speaker 1>patients were reading them and they wanted the drug. There's

0:08:56.559 --> 0:09:00.160
<v Speaker 1>a twist here. The treatment isn't a pill, It a

0:09:00.280 --> 0:09:03.839
<v Speaker 1>radioactive isotope that has to be carefully built in a lab,

0:09:04.679 --> 0:09:07.360
<v Speaker 1>and Dr del Pasand just happens to be also the

0:09:07.400 --> 0:09:10.240
<v Speaker 1>CEO of a company who has the equipment to make it.

0:09:11.120 --> 0:09:13.600
<v Speaker 1>So he got permission from the U S regulators and

0:09:13.640 --> 0:09:16.080
<v Speaker 1>the company that owned the rights to the therapy and

0:09:16.240 --> 0:09:19.800
<v Speaker 1>ramped up production. In that way, I was able to

0:09:19.920 --> 0:09:24.960
<v Speaker 1>actually provide this necessary treatment to my patients and they

0:09:24.960 --> 0:09:28.600
<v Speaker 1>were able to get this treatment in US and in

0:09:28.679 --> 0:09:33.439
<v Speaker 1>Houston versus UH instead of going across the ocean to Europe.

0:09:34.000 --> 0:09:37.319
<v Speaker 1>Dr del Pasand initially had FDA approval to give the

0:09:37.400 --> 0:09:41.880
<v Speaker 1>drug to his patients, but in April, the agency told

0:09:41.920 --> 0:09:45.040
<v Speaker 1>him he was interfering with efforts to get the treatment approved.

0:09:45.800 --> 0:09:49.360
<v Speaker 1>So at that point, basically I noted that, you know,

0:09:49.640 --> 0:09:53.600
<v Speaker 1>I have to stop treating patients because it's going to

0:09:53.640 --> 0:09:58.040
<v Speaker 1>be illegal for me to continue treatment. Fortunately, for his

0:09:58.120 --> 0:10:00.600
<v Speaker 1>cancer patients, a Right to Try law ALWA was passed

0:10:00.640 --> 0:10:04.320
<v Speaker 1>at the state level in Texas two months later, and

0:10:04.400 --> 0:10:07.400
<v Speaker 1>as a result of this Right to tryl I was

0:10:07.440 --> 0:10:12.640
<v Speaker 1>able to UH to treat hundred seventy eight patients until

0:10:12.679 --> 0:10:16.680
<v Speaker 1>the drug became approved and commercially available in February of

0:10:16.880 --> 0:10:20.120
<v Speaker 1>two thousand and eighteen a study of the drug used

0:10:20.120 --> 0:10:22.880
<v Speaker 1>by Dr del pasand showed that patients lived for an

0:10:22.880 --> 0:10:26.720
<v Speaker 1>average of thirty months without their cancer progressing. That compared

0:10:26.720 --> 0:10:29.480
<v Speaker 1>to less than nine months for those given standard care.

0:10:30.400 --> 0:10:33.200
<v Speaker 1>The doctor got letters from his patients thanking him for

0:10:33.240 --> 0:10:39.520
<v Speaker 1>his efforts. I asked him to read me excerpts from one.

0:10:40.240 --> 0:10:45.000
<v Speaker 1>Here it says that when I was diagnosed, my daughter

0:10:45.160 --> 0:10:49.120
<v Speaker 1>was just graduating high school and my son just finished

0:10:49.160 --> 0:10:52.439
<v Speaker 1>his first year in college. I have seen both of

0:10:52.480 --> 0:10:56.960
<v Speaker 1>them graduate college and settled into their chosen professions. I

0:10:57.080 --> 0:11:00.439
<v Speaker 1>also have seen each one fall in love with wonderful people.

0:11:01.120 --> 0:11:03.960
<v Speaker 1>I own a business, and my family did not have

0:11:04.160 --> 0:11:07.040
<v Speaker 1>to sell it. All this from the hard work of

0:11:07.200 --> 0:11:11.079
<v Speaker 1>people devorded to helping with the serious challenges in someone's

0:11:11.120 --> 0:11:14.640
<v Speaker 1>life and being assisted by the common sense right to

0:11:14.760 --> 0:11:22.320
<v Speaker 1>try law. It's it's just amazing. I think this is

0:11:22.360 --> 0:11:25.720
<v Speaker 1>the best pay day for when when you read something

0:11:25.800 --> 0:11:30.560
<v Speaker 1>from a patients, from a human being. Uh, it's just

0:11:31.559 --> 0:11:39.200
<v Speaker 1>it's just chriceless. Right to try has now been the

0:11:39.280 --> 0:11:42.280
<v Speaker 1>law of the land on a national level for about

0:11:42.360 --> 0:11:46.120
<v Speaker 1>six months. I have to be honest, I tried really

0:11:46.160 --> 0:11:49.559
<v Speaker 1>hard to find patients, any patients who have gotten an

0:11:49.559 --> 0:11:53.640
<v Speaker 1>experimental medicine under the federal law. No luck so far.

0:11:54.800 --> 0:11:58.200
<v Speaker 1>Some patients and families were very candid with me, saying

0:11:58.200 --> 0:12:00.040
<v Speaker 1>they would never tell if they were getting treat and

0:12:00.160 --> 0:12:03.800
<v Speaker 1>under Right to Try. There's too much risk of a backlash,

0:12:03.960 --> 0:12:07.200
<v Speaker 1>and if you're getting the drug, there's absolutely no benefit

0:12:07.240 --> 0:12:11.760
<v Speaker 1>to going public. Eventually we will find out if anyone's

0:12:11.760 --> 0:12:14.600
<v Speaker 1>getting treatment under Right to Try. The companies have to

0:12:14.640 --> 0:12:17.280
<v Speaker 1>send the f d A a report once a year

0:12:17.800 --> 0:12:21.120
<v Speaker 1>telling the agency about any medicines they provided under the law.

0:12:21.840 --> 0:12:25.920
<v Speaker 1>We still don't know exactly when that will be. Not

0:12:26.120 --> 0:12:29.280
<v Speaker 1>everyone agrees that dying patients should have unfettered access to

0:12:29.400 --> 0:12:35.240
<v Speaker 1>unapproved drugs. Experimental medicines are precious and unpredictable things. You

0:12:35.320 --> 0:12:38.959
<v Speaker 1>have to be careful with both. When the medicines do work,

0:12:39.320 --> 0:12:42.520
<v Speaker 1>when they really are going to save lives, proving their

0:12:42.559 --> 0:12:46.880
<v Speaker 1>efficacy and scientific studies has to be the priority. Controlled

0:12:46.880 --> 0:12:49.440
<v Speaker 1>clinical studies are also the best way to protect patients

0:12:49.440 --> 0:12:53.760
<v Speaker 1>from harm even death when they don't work. I was

0:12:53.800 --> 0:12:56.960
<v Speaker 1>surprised about who's opposed to Right to Try. The laws

0:12:57.000 --> 0:13:02.240
<v Speaker 1>backers believe that cancer patients will really benefit. Otis Browley

0:13:02.320 --> 0:13:05.679
<v Speaker 1>is the chief medical officer of the American Cancer Society.

0:13:06.240 --> 0:13:08.840
<v Speaker 1>He spoke to me from his office in Atlanta, where

0:13:08.840 --> 0:13:12.320
<v Speaker 1>a fire alarm went off while we were talking. I

0:13:12.400 --> 0:13:16.720
<v Speaker 1>have come to realize that there truly is something worse

0:13:16.760 --> 0:13:23.080
<v Speaker 1>than dying from cancer. I've seen people suffer getting drugs

0:13:23.120 --> 0:13:27.040
<v Speaker 1>for a treatment and then not have benefit. I have seen,

0:13:27.600 --> 0:13:32.880
<v Speaker 1>even in standard practice, people who were tortured because of treatment.

0:13:33.000 --> 0:13:36.360
<v Speaker 1>I just don't want to see that um ever again.

0:13:36.760 --> 0:13:39.560
<v Speaker 1>Dr Browley is concerned that the right to try law

0:13:39.600 --> 0:13:43.360
<v Speaker 1>will exploit people who have no other options. One of

0:13:43.360 --> 0:13:46.520
<v Speaker 1>the problems with people who are in this situation I've

0:13:46.559 --> 0:13:50.120
<v Speaker 1>talked to many of them is sometimes I fear that

0:13:50.160 --> 0:13:53.640
<v Speaker 1>they see too much hope in the drug and don't

0:13:53.720 --> 0:13:57.240
<v Speaker 1>really appreciate what we're talking about in terms of harms.

0:13:57.840 --> 0:14:01.160
<v Speaker 1>Keep in mind, I'm somebody who wants these people to

0:14:01.240 --> 0:14:05.000
<v Speaker 1>be able to have access to these drugs if they

0:14:05.000 --> 0:14:09.280
<v Speaker 1>are well informed and understand. My problem is, I know

0:14:09.400 --> 0:14:12.840
<v Speaker 1>a large number of people are not well informed and understand.

0:14:13.480 --> 0:14:16.839
<v Speaker 1>Dr Browley's point was that sometimes hope can be misleading.

0:14:17.440 --> 0:14:20.120
<v Speaker 1>Most medicines don't make it through. Is that correct. It

0:14:20.280 --> 0:14:24.440
<v Speaker 1>is absolutely correct. Most of the medicines that we have

0:14:25.080 --> 0:14:29.000
<v Speaker 1>theoretic belief that it's going to be beneficial for cancer,

0:14:29.600 --> 0:14:34.160
<v Speaker 1>so much belief that we actually start clinical trials in

0:14:34.280 --> 0:14:38.000
<v Speaker 1>those drugs to figure out if they work and figure

0:14:38.040 --> 0:14:42.720
<v Speaker 1>out if they improve outcome. We find that most of

0:14:42.760 --> 0:14:47.040
<v Speaker 1>those drugs actually fail. So most people who are going

0:14:47.080 --> 0:14:50.000
<v Speaker 1>to be getting these drugs through Right to Try UM

0:14:50.920 --> 0:14:53.440
<v Speaker 1>are going to get drugs that aren't going to work,

0:14:54.240 --> 0:14:59.160
<v Speaker 1>but some undoubtedly will work, and that creates another problem.

0:14:59.320 --> 0:15:02.400
<v Speaker 1>Companies are focused on developing medicines for big groups of

0:15:02.440 --> 0:15:05.840
<v Speaker 1>people who suffer from a disease. In the early days,

0:15:06.120 --> 0:15:09.960
<v Speaker 1>they can't make big batches just enough for studies, and

0:15:10.000 --> 0:15:13.239
<v Speaker 1>the drugs can be hard to make. It's a particular

0:15:13.280 --> 0:15:16.480
<v Speaker 1>problem at small biotech companies that are often the engine

0:15:16.520 --> 0:15:19.960
<v Speaker 1>of innovation. They work on tighter budgets and are more

0:15:20.080 --> 0:15:25.320
<v Speaker 1>vulnerable to mishaps. Typically, patients are very sick, and giving

0:15:25.320 --> 0:15:27.880
<v Speaker 1>away treatment to a single patient under Right to Try

0:15:28.040 --> 0:15:31.560
<v Speaker 1>could jeopardize the entire research effort if something goes wrong.

0:15:32.160 --> 0:15:35.000
<v Speaker 1>If someone is taking one of these drugs and you're

0:15:35.040 --> 0:15:39.120
<v Speaker 1>not in an established clinical trial where people can learn

0:15:39.160 --> 0:15:44.200
<v Speaker 1>about that experience on the drug, then you're actually slowing

0:15:44.280 --> 0:15:48.120
<v Speaker 1>down the development of the drug for everybody else. It

0:15:48.200 --> 0:15:52.240
<v Speaker 1>really is selfish. It's not a theoretical risk. Some companies

0:15:52.280 --> 0:15:55.120
<v Speaker 1>have trouble in enrolling early stage studies, known as phase

0:15:55.160 --> 0:15:58.360
<v Speaker 1>one and phase two. Allowing some patients to have the

0:15:58.400 --> 0:16:02.000
<v Speaker 1>experimental drug without participating in a trial could make the

0:16:02.040 --> 0:16:06.640
<v Speaker 1>process harder. I really want people to go into those

0:16:06.680 --> 0:16:10.960
<v Speaker 1>phase one and phase two clinical trials and really try

0:16:11.000 --> 0:16:15.800
<v Speaker 1>to help us to move cancer medicine forward as expeditiously

0:16:16.040 --> 0:16:22.480
<v Speaker 1>and as efficiently as possible. Dr Browley isn't against patients

0:16:22.480 --> 0:16:25.800
<v Speaker 1>getting fast access to promising new drugs. He just wants

0:16:25.840 --> 0:16:28.840
<v Speaker 1>to capture all the information possible about how they work,

0:16:29.360 --> 0:16:32.680
<v Speaker 1>preferably in a monitored setting, and he wants to protect

0:16:32.680 --> 0:16:39.120
<v Speaker 1>the patients who are taking experimental drugs from unintended harm.

0:16:39.280 --> 0:16:42.920
<v Speaker 1>Remember before Right to Try, terminally ill patients could get

0:16:42.960 --> 0:16:46.600
<v Speaker 1>experimental drugs under the FDA's Compassionate Use Program, which is

0:16:46.600 --> 0:16:50.440
<v Speaker 1>also known as Expanded Access. In recent years, it's approved

0:16:50.440 --> 0:16:55.520
<v Speaker 1>more than of applications. F d A Commissioner Scott god Leaves,

0:16:55.560 --> 0:16:59.560
<v Speaker 1>a fan of Expanded access Right to Try, not so much.

0:17:00.120 --> 0:17:02.480
<v Speaker 1>He declined to talk to us for this podcast, but

0:17:02.560 --> 0:17:07.200
<v Speaker 1>he did testify before Congress about the topic in right now,

0:17:07.240 --> 0:17:11.760
<v Speaker 1>our expanded access program is generally available for patients facing

0:17:12.520 --> 0:17:16.200
<v Speaker 1>life threatening conditions and terminal illness. The agency has gotten

0:17:16.240 --> 0:17:19.920
<v Speaker 1>even more vigilant at trying to move these things through

0:17:19.960 --> 0:17:22.919
<v Speaker 1>the agency in a in a efficient fashion and approve

0:17:23.040 --> 0:17:26.480
<v Speaker 1>these The FDA also has access to information that no

0:17:26.560 --> 0:17:30.639
<v Speaker 1>single doctor or patient has. It knows if complications cropped

0:17:30.680 --> 0:17:33.840
<v Speaker 1>up with earlier use of the drug or with similar medicines.

0:17:34.600 --> 0:17:38.920
<v Speaker 1>Such side effects aren't always immediately disclosed. The FDA's guidance

0:17:38.960 --> 0:17:47.439
<v Speaker 1>can help make sure experimental drugs are used safely. Drug

0:17:47.480 --> 0:17:51.040
<v Speaker 1>makers have the last word on their medicines, and it's

0:17:51.080 --> 0:17:54.320
<v Speaker 1>tempting to point the finger at pharmaceutical companies that say

0:17:54.359 --> 0:17:58.360
<v Speaker 1>no to a desperate patient, But it's more complicated than that.

0:17:59.359 --> 0:18:02.600
<v Speaker 1>Drug maker have been grappling with these requests for years.

0:18:03.520 --> 0:18:07.960
<v Speaker 1>Johnson and Johnson's chief medical officer, Joanne wald Striker says

0:18:07.960 --> 0:18:10.879
<v Speaker 1>it's one of the hardest and most heartbreaking parts of

0:18:10.920 --> 0:18:16.160
<v Speaker 1>her job. Sometimes, before we know everything about our products

0:18:16.160 --> 0:18:19.439
<v Speaker 1>in advance of getting approvals from the health authorities like

0:18:19.520 --> 0:18:21.840
<v Speaker 1>the f d A, before they even get to see

0:18:21.880 --> 0:18:25.359
<v Speaker 1>the data on the product, we sometimes get requests for

0:18:25.480 --> 0:18:30.160
<v Speaker 1>our products from patients and families around the globe who

0:18:30.200 --> 0:18:34.560
<v Speaker 1>have exhausted all other options for treatment. There's a long

0:18:34.680 --> 0:18:38.840
<v Speaker 1>list of issues the company has to consider when evaluating requests.

0:18:39.720 --> 0:18:42.880
<v Speaker 1>Is there enough medicine available, We'll giving it to one

0:18:42.920 --> 0:18:46.040
<v Speaker 1>patient make it harder to enroll others in clinical trials.

0:18:47.080 --> 0:18:50.280
<v Speaker 1>If J and JA gets more requests than the available supply,

0:18:50.800 --> 0:18:54.280
<v Speaker 1>who gets the drug and who doesn't? And if things

0:18:54.320 --> 0:18:57.440
<v Speaker 1>go wrong and if fragile patient dies, will that put

0:18:57.480 --> 0:19:00.840
<v Speaker 1>the drugs entire development in jeopardy. We have to weigh

0:19:00.840 --> 0:19:04.320
<v Speaker 1>the need of an individual person and family who's requesting

0:19:04.359 --> 0:19:09.520
<v Speaker 1>access versus the needs of society, versus our our obligation

0:19:09.680 --> 0:19:12.840
<v Speaker 1>to society into public health. And that is a real

0:19:13.119 --> 0:19:17.199
<v Speaker 1>bioethic challenge that we face. And you can imagine if

0:19:17.280 --> 0:19:19.640
<v Speaker 1>a person is enrolled in a clinical trial and they

0:19:19.680 --> 0:19:23.359
<v Speaker 1>have the chance of getting either the drug or the placebo,

0:19:23.520 --> 0:19:26.119
<v Speaker 1>it may not be fair to that person if we

0:19:26.240 --> 0:19:28.840
<v Speaker 1>decide to give access to someone else outside of the

0:19:28.840 --> 0:19:32.320
<v Speaker 1>clinical trial setting, just because they asked and they're not

0:19:32.359 --> 0:19:34.439
<v Speaker 1>going into a study where they have a chance of

0:19:34.480 --> 0:19:38.760
<v Speaker 1>getting either drug or placebo. Hanging over the entire issue

0:19:39.200 --> 0:19:43.119
<v Speaker 1>is fairness. Some families and patients have the wherewithal to

0:19:43.240 --> 0:19:47.760
<v Speaker 1>create powerful social media campaigns to shame companies or to

0:19:47.800 --> 0:19:50.600
<v Speaker 1>try to force them to make an experimental medicine available,

0:19:51.240 --> 0:19:55.120
<v Speaker 1>especially for children. But if there's one child who needs

0:19:55.119 --> 0:19:58.399
<v Speaker 1>an experimental drug, there are likely more. We have to

0:19:58.440 --> 0:20:01.600
<v Speaker 1>treat people in clinical trials early. But also we want

0:20:01.640 --> 0:20:06.040
<v Speaker 1>to treat people in all different socioeconomic circumstances fairly. If

0:20:06.080 --> 0:20:09.240
<v Speaker 1>we get a request of someone who's a public figure,

0:20:09.680 --> 0:20:12.760
<v Speaker 1>someone who's in the government, someone who's very wealthy, we

0:20:12.800 --> 0:20:15.760
<v Speaker 1>want to be sure we're treating those requests the same

0:20:15.800 --> 0:20:18.359
<v Speaker 1>as people who have a need who may not be

0:20:18.400 --> 0:20:21.959
<v Speaker 1>in those circumstances. We want to treat everyone fairly, and

0:20:22.000 --> 0:20:26.600
<v Speaker 1>so that's why this is such a challenging issue for us.

0:20:26.600 --> 0:20:29.439
<v Speaker 1>So the company decided to bring in outside experts to

0:20:29.520 --> 0:20:33.600
<v Speaker 1>help deal with all these issues. In twenty fifteen, we

0:20:33.720 --> 0:20:36.840
<v Speaker 1>approached the Division of Medical Ethics at the n y

0:20:36.960 --> 0:20:40.000
<v Speaker 1>U School of Medicine to really help us think this through.

0:20:40.480 --> 0:20:44.560
<v Speaker 1>Instead of physicians like myself at Johnson and Johnson reviewing

0:20:44.600 --> 0:20:48.320
<v Speaker 1>every request and then having individual teams try to juggle

0:20:48.400 --> 0:20:52.080
<v Speaker 1>and make this difficult bioethical decision in terms of whether

0:20:52.080 --> 0:20:56.240
<v Speaker 1>to provide the product. The requests go to this group

0:20:56.280 --> 0:21:00.480
<v Speaker 1>called the Compassionate Access Group Compact. You know, I feel

0:21:00.800 --> 0:21:07.719
<v Speaker 1>very strongly that people who have such important medical needs

0:21:07.800 --> 0:21:10.800
<v Speaker 1>and who are in such urgent situations should have a

0:21:10.920 --> 0:21:13.760
<v Speaker 1>level of control over what happens to them. And I

0:21:13.840 --> 0:21:16.280
<v Speaker 1>sympathize and I understand that they want to be able

0:21:16.320 --> 0:21:20.800
<v Speaker 1>to access experimental medicines. But on the other hand, at

0:21:20.800 --> 0:21:23.760
<v Speaker 1>a time like that, when you're desperate to try anything,

0:21:24.359 --> 0:21:28.200
<v Speaker 1>it's a time when expert input really can help make

0:21:28.200 --> 0:21:31.560
<v Speaker 1>a difference. Of course, Jay and J is an outlier.

0:21:32.119 --> 0:21:34.760
<v Speaker 1>It's the biggest health care company in the world with

0:21:34.880 --> 0:21:39.199
<v Speaker 1>unmatched resources. Clearly, not every company can afford to do

0:21:39.320 --> 0:21:42.359
<v Speaker 1>what it does, but it is a start, right to

0:21:42.400 --> 0:21:44.400
<v Speaker 1>try us put the f d A and the industry

0:21:44.400 --> 0:21:47.240
<v Speaker 1>on notice that the immediate needs of patients must be

0:21:47.320 --> 0:21:54.600
<v Speaker 1>taken into account. Laura McGlynn, the woman we met at

0:21:54.640 --> 0:21:57.680
<v Speaker 1>the beginning of this episode, is taking it day by day.

0:21:57.880 --> 0:22:00.240
<v Speaker 1>Her son Jordan, is enrolled in a clinical try aisle,

0:22:00.720 --> 0:22:03.840
<v Speaker 1>but she believes one day he'll need other medicines, and

0:22:03.880 --> 0:22:07.200
<v Speaker 1>that's why she keeps fighting. I feel proud to know that,

0:22:07.400 --> 0:22:10.399
<v Speaker 1>you know, my son played a part in helping create

0:22:10.440 --> 0:22:13.720
<v Speaker 1>this additional pathway, so rather Jordan is able to access

0:22:13.800 --> 0:22:18.000
<v Speaker 1>better treatments in the future through clinical trials, through um

0:22:18.320 --> 0:22:21.600
<v Speaker 1>compassionate use, through right to try, through maybe you know

0:22:21.960 --> 0:22:25.080
<v Speaker 1>an f D approved drug. I'm just glad to know

0:22:25.160 --> 0:22:29.080
<v Speaker 1>that there are options available and to those who feel

0:22:29.119 --> 0:22:31.760
<v Speaker 1>like right to try as a shortcut a form of

0:22:31.800 --> 0:22:35.120
<v Speaker 1>cutting in line that could hurt someone else. I don't

0:22:35.200 --> 0:22:37.680
<v Speaker 1>let my mind go there as far as thinking about

0:22:37.760 --> 0:22:40.720
<v Speaker 1>what's fair or not fair if a life is saved,

0:22:40.800 --> 0:22:43.560
<v Speaker 1>or if someone has a chance to try to save

0:22:43.560 --> 0:22:46.920
<v Speaker 1>their own life and they want to, I don't care.

0:22:47.280 --> 0:22:50.080
<v Speaker 1>It's one life at a time, and that's to me,

0:22:50.200 --> 0:23:03.399
<v Speaker 1>that's what matters. And that's it for this week's prognosis.

0:23:03.640 --> 0:23:06.600
<v Speaker 1>Thanks for listening. Do you have a story about healthcare

0:23:06.640 --> 0:23:09.240
<v Speaker 1>in the US or around the world, We want to

0:23:09.280 --> 0:23:12.399
<v Speaker 1>hear from you. You can email me m Cortes at

0:23:12.400 --> 0:23:15.720
<v Speaker 1>Bloomberg dot net or find me on Twitter at bay Cortes.

0:23:16.440 --> 0:23:18.880
<v Speaker 1>If you were a fan of this episode, please take

0:23:18.880 --> 0:23:21.200
<v Speaker 1>a moment to rate and review us. It helps new

0:23:21.240 --> 0:23:25.840
<v Speaker 1>listeners find the show. This episode was produced by Lindsay Cratterwell.

0:23:26.440 --> 0:23:29.800
<v Speaker 1>Our story editor was Cecile Durraant. Thanks also to Drew

0:23:29.920 --> 0:23:34.160
<v Speaker 1>Armstrong Francesca Leavi as head of Bloomberg Podcasts. We'll see

0:23:34.200 --> 0:23:34.760
<v Speaker 1>you next week.